KLP Kapitalforvaltning AS Buys Shares of 9,800 Omnicell, Inc. (NASDAQ:OMCL)

KLP Kapitalforvaltning AS acquired a new stake in shares of Omnicell, Inc. (NASDAQ:OMCL) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 9,800 shares of the company’s stock, valued at approximately $436,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Hillsdale Investment Management Inc. boosted its stake in Omnicell by 0.5% during the fourth quarter. Hillsdale Investment Management Inc. now owns 92,897 shares of the company’s stock valued at $4,136,000 after buying an additional 420 shares in the last quarter. Sei Investments Co. bought a new position in shares of Omnicell during the 4th quarter valued at about $313,000. Quantbot Technologies LP grew its stake in shares of Omnicell by 36.8% in the 4th quarter. Quantbot Technologies LP now owns 25,422 shares of the company’s stock worth $1,132,000 after purchasing an additional 6,841 shares during the last quarter. Teacher Retirement System of Texas raised its holdings in shares of Omnicell by 59.0% in the 4th quarter. Teacher Retirement System of Texas now owns 26,682 shares of the company’s stock worth $1,188,000 after purchasing an additional 9,896 shares in the last quarter. Finally, Trillium Asset Management LLC lifted its stake in Omnicell by 12.5% during the fourth quarter. Trillium Asset Management LLC now owns 144,115 shares of the company’s stock valued at $6,416,000 after purchasing an additional 16,040 shares during the last quarter. Institutional investors own 97.70% of the company’s stock.

Omnicell Stock Performance

OMCL opened at $32.69 on Friday. Omnicell, Inc. has a 12-month low of $25.12 and a 12-month high of $55.75. The firm has a market capitalization of $1.53 billion, a P/E ratio of 121.08, a price-to-earnings-growth ratio of 7.53 and a beta of 0.85. The stock’s 50 day moving average price is $38.16 and its two-hundred day moving average price is $42.27. The company has a quick ratio of 1.22, a current ratio of 1.37 and a debt-to-equity ratio of 0.13.

Omnicell (NASDAQ:OMCL) last announced its quarterly earnings data on Thursday, February 6th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($0.12). Omnicell had a return on equity of 3.82% and a net margin of 1.13%. On average, equities analysts forecast that Omnicell, Inc. will post 1.09 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Benchmark reaffirmed a “buy” rating and issued a $62.00 price objective on shares of Omnicell in a research note on Tuesday, February 4th. Bank of America lowered their target price on shares of Omnicell from $54.00 to $46.00 and set a “neutral” rating on the stock in a research report on Monday, January 6th. StockNews.com lowered Omnicell from a “buy” rating to a “hold” rating in a report on Monday, March 24th. JPMorgan Chase & Co. decreased their target price on Omnicell from $44.00 to $36.00 and set a “neutral” rating for the company in a research report on Thursday, March 20th. Finally, Wells Fargo & Company dropped their price target on shares of Omnicell from $49.00 to $40.00 and set an “equal weight” rating on the stock in a research report on Monday, January 13th. Five investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $51.00.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.